79 related articles for article (PubMed ID: 31199560)
21. Transcriptome Profiling Reveals Differential Expression of Circadian Behavior Genes in Peripheral Blood of Monozygotic Twins Discordant for Parkinson's Disease.
Semenova EI; Vlasov IN; Partevian SA; Rosinskaya AV; Rybolovlev IN; Slominsky PA; Shadrina MI; Alieva AK
Cells; 2022 Aug; 11(16):. PubMed ID: 36010675
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease.
Labandeira CM; Pedrosa MA; Quijano A; Valenzuela R; Garrido-Gil P; Sanchez-Andrade M; Suarez-Quintanilla JA; Rodriguez-Perez AI; Labandeira-Garcia JL
NPJ Parkinsons Dis; 2022 Jun; 8(1):76. PubMed ID: 35701430
[TBL] [Abstract][Full Text] [Related]
23. A Machine Learning Approach to Parkinson's Disease Blood Transcriptomics.
Pantaleo E; Monaco A; Amoroso N; Lombardi A; Bellantuono L; Urso D; Lo Giudice C; Picardi E; Tafuri B; Nigro S; Pesole G; Tangaro S; Logroscino G; Bellotti R
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627112
[TBL] [Abstract][Full Text] [Related]
24. Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development.
Ahluwalia K; Ebright B; Chow K; Dave P; Mead A; Poblete R; Louie SG; Asante I
Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448520
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson's Disease and Bipolar Disorder: A Pilot Study.
Hossain MB; Islam MK; Adhikary A; Rahaman A; Islam MZ
Bioinform Biol Insights; 2022; 16():11779322221079232. PubMed ID: 35221677
[TBL] [Abstract][Full Text] [Related]
26. Associations of ARHGAP26 Polymorphisms with Alzheimer's Disease and Cardiovascular Disease.
Wang K; Lu Y; Morrow DF; Xiao D; Xu C;
J Mol Neurosci; 2022 May; 72(5):1085-1097. PubMed ID: 35171450
[TBL] [Abstract][Full Text] [Related]
27. Multiple Criteria Optimization (MCO): A gene selection deterministic tool in RStudio.
Narváez-Bandera I; Suárez-Gómez D; Isaza CE; Cabrera-Ríos M
PLoS One; 2022; 17(1):e0262890. PubMed ID: 35085348
[TBL] [Abstract][Full Text] [Related]
28. Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson's Disease.
Aguila J; Cheng S; Kee N; Cao M; Wang M; Deng Q; Hedlund E
Front Mol Neurosci; 2021; 14():699562. PubMed ID: 34305528
[TBL] [Abstract][Full Text] [Related]
29. Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients.
Karaaslan Z; Kahraman ÖT; Şanlı E; Ergen HA; Ulusoy C; Bilgiç B; Yılmaz V; Tüzün E; Hanağası HA; Küçükali Cİ
Sci Rep; 2021 Jan; 11(1):2316. PubMed ID: 33504893
[TBL] [Abstract][Full Text] [Related]
30. Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms.
Váradi C
Biology (Basel); 2020 May; 9(5):. PubMed ID: 32438686
[TBL] [Abstract][Full Text] [Related]
31. Identification of biomarkers associated with Parkinson's disease by gene expression profiling studies and bioinformatics analysis.
Krokidis MG
AIMS Neurosci; 2019; 6(4):333-345. PubMed ID: 32341987
[TBL] [Abstract][Full Text] [Related]
32. Dysregulated Long Non-coding RNAs in Parkinson's Disease Contribute to the Apoptosis of Human Neuroblastoma Cells.
Fan Y; Li J; Yang Q; Gong C; Gao H; Mao Z; Yuan X; Zhu S; Xue Z
Front Neurosci; 2019; 13():1320. PubMed ID: 31920490
[TBL] [Abstract][Full Text] [Related]
33. A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson's disease.
Sakharkar MK; Kashmir Singh SK; Rajamanickam K; Mohamed Essa M; Yang J; Chidambaram SB
PLoS One; 2019; 14(9):e0220995. PubMed ID: 31487305
[TBL] [Abstract][Full Text] [Related]
34. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
George G; Valiya Parambath S; Lokappa SB; Varkey J
Gene; 2019 May; 697():67-77. PubMed ID: 30776463
[TBL] [Abstract][Full Text] [Related]
35. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
36. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
[TBL] [Abstract][Full Text] [Related]
37. Expanding the search for genetic biomarkers of Parkinson's disease into the living brain.
Benoit SM; Xu H; Schmid S; Alexandrova R; Kaur G; Thiruvahindrapuram B; Pereira SL; Jog M; Hebb MO
Neurobiol Dis; 2020 Jul; 140():104872. PubMed ID: 32302674
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers in Parkinson's disease.
Morgan JC; Mehta SH; Sethi KD
Curr Neurol Neurosci Rep; 2010 Nov; 10(6):423-30. PubMed ID: 20809400
[TBL] [Abstract][Full Text] [Related]
39. Identification of potential diagnostic biomarkers for Parkinson's disease.
Jiang F; Wu Q; Sun S; Bi G; Guo L
FEBS Open Bio; 2019 Aug; 9(8):1460-1468. PubMed ID: 31199560
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
